blocks_image
+44(0)7932 030724 Contact Us
Regulatory Services

Implementation of an appropriate regulatory strategy is critical to efficient drug development and the successful approval of products. Grove Healthcare has significant experience in helping clients understand regulatory requirements and assess their regulatory strategy.
 
Grove Healthcare provides regulatory expertise and resource throughout all stages of product
development to enhance submission preparation and achieve faster product approval. Grove can provide guidance on mutual recognition procedures, product registration, price assessments, variation submissions, artwork and packaging submissions. All applications are followed-up regularly at local level. Good working relationships with Ministry of Health personnel and Key Opinion Leaders result in an efficient approval process.
 
Grove Healthcare can also provide pharmacoviligance services in all our markets to ensure medicinal hazards are identified promptly and patient safety is maintained. In the past few years new directives and regulations have been implemented to enhance the way in which patient safety monitoring is conducted. Some of these new requirements create a significant burden both in terms of resources, expertise and time needed to ensure compliance. Grove Healthcare can assist with this burden.
The Grove CEE Conference 2010

Every year Grove Healthcare hosts a conference focusing on the CEE pharmaceutical market.
This year the conference will be held in
Lithuania between the 04th and 08th October.
If you would like to attend, either to present your company and products, or to learn more about the CEE market and the Grove Group please contact
klausdoring@groveonline.com for more details.